ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Garb Raps “Hostility Of Executive Branch”; Hew Considers Allowing Grants For Industry

April 25, 1980

IVAX And It’s Portfolio

December 22, 1994

DCT Board Okays New Surgery RFA, Will Hear Request For Support Of 30 Surgical Centers

April 11, 1980

Obit: J. Gale Katterhagen, NCAB’s First Community Physician.

May 4, 2001

NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients

November 11, 2011

Bush Budget Reinforces Funding Trends, Reports Say.

July 13, 2001